This multicenter prospective observational study examines the efficacy of palliative care team interventions in managing nutrition impact symptoms and eating-related distress among patients with ...

Targeted therapies may improve survival in these patients by concurrently managing immune dysregulation and the leukemic clone. Targeted therapies appear to mitigate the adverse prognostic impact of ...

A phase 3 randomized controlled trial tested specialized immunonutrition vs standard nutrition before radical cystectomy for bladder cancer.

In this retrospective study, researchers aimed to evaluate the impact of a positive genetic test on patients’ surgical decision-making.

This umbrella review evaluates the effectiveness of artificial intelligence-based nursing interventions for managing chronic illness.

Complete response reported in 75 percent of patients with BCG-unresponsive, non-muscle-invasive bladder cancer.

This systematic evaluation of 54 target trial emulation studies in oncology examines their study characteristics, key protocol components, and consistency with corresponding randomized controlled ...

The sBLA is supported by phase 1b/2 OrigAMI-4 trial data demonstrating a 42% confirmed overall response rate in pretreated patients with recurrent or metastatic head and neck squamous cell carcinoma.

A new model, based on factors identified via machine learning, predicts overall survival at 1, 3, and 5 years after nephrectomy for nonmetastatic renal cell carcinoma (RCC). A separate study suggests ...

A study evaluates the feasibility and clinical utility of integrating routine, electronic patient-reported outcome screening into a dedicated thyroid cancer survivorship clinic to monitor long-term ...

A multisociety consensus statement outlines recommendations for modernizing radiation protection equipment in interventional and fluoroscopy suites.

Researchers compared survival outcomes in patients with non-small cell lung cancer who underwent surgical resection vs radiotherapy.